Showing 5071-5080 of 8624 results for "".
- Soliton Takes On Cellulitehttps://practicaldermatology.com/news/soliton-takes-on-cellulite-2/2460049/Soliton, Inc.’s Rapid Acoustic Pulse ("RAP") device may selectively disrupt of the fibrotic septa that contribute to the appearance of cellulite, according to preclinical studies. The device is cleated for use in tattoo removal, howe
- New NRS Study Shows Positive Impact of Clear Skin in Rosacea Patientshttps://practicaldermatology.com/news/new-nrs-study-shows-positive-impact-of-clear-skin-in-rosacea-patients/2460048/Treating rosacea can have a major positive impact on patients’ lives, according to a new survey by the National Rosacea Society. In the survey of 1,044 rosacea patients, around 76 percent of all respondents saw at least some improvement in th
- Laser Microscope Can Diagnose Skin Cancer and Perform Surgeryhttps://practicaldermatology.com/news/specialized-microscope-can-diagnose-skin-cancer-and-perform-surgery/2460045/University of British Columbia researchers have developed a specialized microscope that has the potential ability to both diagnose diseases including skin cancer and perform incredibly precise surgery--all without cutting skin. The researchers describe the technology in
- Positive 90-Day Results from CONFORM Study: Recros Medicahttps://practicaldermatology.com/news/positive-90-day-results-from-conform-study-recros-medica/2460042/Ninety-day results from the CONFORM study assessing the efficacy, safety, and patient satisfaction of the Rotational Fractional Resection (RFR) procedure for submental contouring are promising. RFR is a novel, proprietary alternative to traditional approaches to treat skin laxity developed by
- Constellation Alpha Capital Corp. to Merge with DermTech, Inc.https://practicaldermatology.com/news/constellation-alpha-capital-corp-to-merge-with-dermtech-inc/2460041/Constellation Alpha Capital Corp. is merging with DermTech, Inc., a molecular genomics company with an initial focus on skin cancer. "DermTech has developed a deep pipeline of dermatology-focused dia
- Crown Laboratories Adds to Portfoliohttps://practicaldermatology.com/news/crown-laboratories-adds-to-portfolio/2460040/On the heels of a brand relaunch this week,Crown Laboratories’ Aesthetics division, Bellus Medical, has acquired the HD PRP system for the aesthetic marketplace from Healeon Medical, Inc. The system is designed to meet the demands of busy practices seeking higher volume and higher yiel
- Crown Laboratories Unveils New Corporate Brandinghttps://practicaldermatology.com/news/crown-laboratories-unveils-new-corporate-branding/2460037/Crown Laboratories is launching its new corporate branding. Their new tagline 'Skin Science for Life' highlights the company’s focus on aesthetic medicine, generic and branded dermatological prescription drugs, OTC and prestig
- Hispanic and Black Children More Likely to Miss School Due to Eczema Than White Childrenhttps://practicaldermatology.com/news/hispanic-and-black-children-more-likely-to-miss-school-due-to-eczema-than-white-children/2460036/Hispanic and black children are more likely than white children to miss school due to chronic eczema, a new study in JAMA Dermatology shows. Researchers from the Perelman School of Medicine at the University of Pennsylva
- Nestlé Enters into Negotiations to Sell Nestlé Skin Health to Consortium Led by EQT and ADIAhttps://practicaldermatology.com/news/nestle-enters-into-negotiations-to-sell-nestle-skin-health-to-consortium-led-by-eqt-and-adia/2460031/Nestlé has entered into exclusive negotiations with a consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for the sale of Nestlé Skin Health for a value of CHF 10.2 billion. Nestlé Skin Health
- Skin Cancer Patients Prioritize Cosmetic Outcomes Over Costhttps://practicaldermatology.com/news/skin-cancer-patients-prioritize-cosmetic-outcomes-over-cost/2460030/Skin cancer patients who require surgery on their faces are willing to pay more for a smaller scar, according to a new study in the Journal of the American Academy of Dermatology. Researchers conducted a